Next, analysis of OS and RFS data revealed that EPHX3 can be used as a prognosis marker for HNSCC and that HNSCC patients with low levels of EPHX3 had worse prognosis. The gene discussed is EPHX3; the disease is head and neck squamous cell carcinoma.